Bisphosphonate therapy in multiple myeloma

Acta Oncologica

Volumn 35, Issue SUPPL. 5, 1996, Pages 55-56

  Laakso, Markku ^a   Jantunen, Esa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; PAMIDRONIC ACID; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTURE; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL;

CLINICAL TRIALS; CLODRONIC ACID; DIPHOSPHONATES; HUMANS; MULTIPLE MYELOMA;

EID: 0030497544     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609083969     Document Type: Article

References (7)

1. Lahtinen R, Laakso M, Palva I, Virkkunen P, Elomaa I for the Finnish Leukaemia Group. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Lancet 1992; 340: 1049-1052.
2. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, et al. Mechanism of bone destruction in multiple myeloma: the importance of unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 1989; 7: 1909-1914.
3. Mundy GR. Mechanisms of osteolytic bone destruction. Bone 1991; 12 (Suppl. 1): S1-S6.
4. Jantunen E, Lahtinen R, Laakso M. Use of clodronate in multiple myeloma. Leuk Lymphoma 1995; 19: 207-211.
5. Laakso M, Lahtinen R, Virkkunen P. Elomaa I for the Finnish Leukaemia Group. Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Br J Haematol 1994; 87: 725-729.
6. Belch AR, Bergsagel DE, Wilson K, O'Reilly S, Wilson J, Sutton D, et al. Effect of daily etidronate on the osteolysis of multiple myeloma. J Clin Oncol 1991; 9: 1397-1402.
7. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 1996; 334: 488-493.